Stock listing
NASDAQ:KTTA Pasithea Therapeutics Corp. Stock
Home listing (NASDAQ) of Pasithea Therapeutics Corp.
Follow Pasithea Therapeutics Corp. into a list and get an email when it puts out news.
Share price · NASDAQ:KTTA
$0.37 USD +0.00 (+0.2%)
Close on Oct 30, 2026
- Day range
- $0.36 – $0.389 USDOct 30, 2026
- Volume
- 99,799 sharesOct 30, 2026
- Market cap
- $12.37M USDAt the close on Oct 30, 2026 · price × 33.41M shares outstanding
- 52-week range
- $0.281 – $2.06 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $111,511 USDMedian day 141,600 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:KTTA · Home | $0.37 USD | +0.001 (+0.2%) | 99,799 | $0.37 | $0.389 | $0.36 | $0.37 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:KTTA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.37 | +0.001 | +0.2% | $0.37 | $0.389 | $0.36 | 99,799 | |
| $0.37 | -0.023 | -6.0% | $0.381 | $0.407 | $0.351 | 329,714 | |
| $0.393 | -0.004 | -1.1% | $0.39 | $0.40 | $0.371 | 596,824 | |
| $0.397 | -0.003 | -0.7% | $0.38 | $0.425 | $0.376 | 649,129 | |
| $0.40 | -0.005 | -1.3% | $0.392 | $0.412 | $0.372 | 628,873 | |
| $0.405 | -0.04 | -9.0% | $0.45 | $0.471 | $0.345 | 1,533,400 | |
| $0.445 | -0.043 | -8.8% | $0.488 | $0.50 | $0.445 | 378,800 | |
| $0.488 | +0.078 | +19.0% | $0.425 | $0.497 | $0.42 | 774,900 | |
| $0.41 | -0.002 | -0.5% | $0.413 | $0.415 | $0.41 | 38,500 | |
| $0.412 | -0.008 | -1.9% | $0.443 | $0.443 | $0.41 | 18,500 | |
| $0.42 | +0.01 | +2.4% | $0.41 | $0.43 | $0.40 | 209,300 | |
| $0.41 | +0.001 | +0.2% | $0.409 | $0.438 | $0.398 | 20,600 | |
| $0.409 | -0.015 | -3.5% | $0.44 | $0.44 | $0.383 | 616,500 | |
| $0.424 | -0.024 | -5.4% | $0.45 | $0.45 | $0.41 | 60,100 | |
| $0.448 | -0.02 | -4.3% | $0.466 | $0.466 | $0.447 | 80,700 | |
| $0.468 | +0.027 | +6.1% | $0.45 | $0.468 | $0.45 | 60,600 | |
| $0.441 | -0.002 | -0.5% | $0.452 | $0.468 | $0.441 | 56,200 | |
| $0.443 | -0.004 | -0.9% | $0.447 | $0.468 | $0.44 | 132,500 | |
| $0.447 | -0.008 | -1.8% | $0.465 | $0.465 | $0.44 | 64,100 | |
| $0.455 | -0.021 | -4.4% | $0.486 | $0.51 | $0.455 | 84,600 | |
| $0.476 | -0.013 | -2.7% | $0.475 | $0.509 | $0.475 | 59,800 | |
| $0.489 | -0.004 | -0.8% | $0.493 | $0.503 | $0.48 | 12,000 | |
| $0.493 | +0.003 | +0.6% | $0.489 | $0.51 | $0.477 | 60,000 | |
| $0.49 | +0.01 | +2.1% | $0.475 | $0.496 | $0.46 | 141,500 | |
| $0.48 | -0.019 | -3.8% | $0.489 | $0.50 | $0.452 | 151,200 | |
| $0.499 | -0.015 | -2.9% | $0.50 | $0.51 | $0.485 | 94,800 | |
| $0.514 | +0.001 | +0.2% | $0.503 | $0.53 | $0.503 | 105,100 | |
| $0.513 | -0.001 | -0.2% | $0.508 | $0.52 | $0.502 | 113,900 | |
| $0.514 | +0.004 | +0.8% | $0.53 | $0.53 | $0.495 | 165,000 | |
| $0.51 | -0.014 | -2.7% | $0.51 | $0.517 | $0.495 | 67,600 | |
| $0.524 | +0.017 | +3.4% | $0.525 | $0.55 | $0.488 | 483,200 | |
| $0.507 | +0.017 | +3.5% | $0.49 | $0.514 | $0.474 | 238,000 | |
| $0.49 | -0.01 | -2.0% | $0.50 | $0.51 | $0.49 | 79,800 | |
| $0.50 | -0.01 | -2.0% | $0.498 | $0.529 | $0.491 | 280,400 | |
| $0.51 | -0.02 | -3.8% | $0.523 | $0.549 | $0.51 | 135,700 | |
| $0.53 | -0.01 | -1.9% | $0.531 | $0.552 | $0.52 | 141,700 | |
| $0.54 | -0.03 | -5.3% | $0.57 | $0.576 | $0.52 | 246,900 | |
| $0.57 | -0.029 | -4.8% | $0.599 | $0.599 | $0.551 | 210,200 | |
| $0.599 | +0.019 | +3.3% | $0.587 | $0.60 | $0.58 | 267,300 | |
| $0.58 | 0.00 | 0.0% | $0.58 | $0.593 | $0.57 | 222,700 | |
| $0.58 | 0.00 | 0.0% | $0.58 | $0.595 | $0.575 | 124,400 | |
| $0.58 | +0.017 | +3.0% | $0.56 | $0.595 | $0.55 | 225,700 | |
| $0.563 | -0.011 | -1.9% | $0.557 | $0.578 | $0.55 | 216,400 | |
| $0.574 | +0.014 | +2.5% | $0.573 | $0.586 | $0.55 | 449,800 | |
| $0.56 | +0.005 | +0.9% | $0.574 | $0.604 | $0.534 | 483,900 | |
| $0.555 | -0.015 | -2.6% | $0.576 | $0.577 | $0.549 | 66,900 | |
| $0.57 | +0.01 | +1.8% | $0.569 | $0.58 | $0.531 | 94,700 | |
| $0.56 | +0.055 | +10.9% | $0.533 | $0.571 | $0.525 | 223,840 | |
| $0.505 | -0.034 | -6.3% | $0.523 | $0.573 | $0.49 | 339,046 | |
| $0.539 | +0.069 | +14.7% | $0.489 | $0.539 | $0.48 | 301,500 | |
| $0.47 | -0.02 | -4.1% | $0.485 | $0.487 | $0.47 | 108,000 | |
| $0.49 | -0.008 | -1.6% | $0.498 | $0.51 | $0.488 | 89,300 | |
| $0.498 | +0.02 | +4.2% | $0.505 | $0.51 | $0.484 | 105,200 | |
| $0.478 | -0.003 | -0.6% | $0.487 | $0.512 | $0.44 | 178,000 | |
| $0.481 | +0.003 | +0.6% | $0.478 | $0.495 | $0.476 | 43,300 | |
| $0.478 | -0.012 | -2.4% | $0.498 | $0.498 | $0.475 | 56,800 | |
| $0.49 | +0.013 | +2.7% | $0.49 | $0.51 | $0.486 | 140,200 | |
| $0.477 | +0.003 | +0.7% | $0.475 | $0.49 | $0.466 | 73,452 | |
| $0.474 | -0.033 | -6.5% | $0.49 | $0.526 | $0.473 | 541,948 | |
| $0.507 | +0.063 | +14.2% | $0.458 | $0.511 | $0.44 | 375,800 | |
| $0.444 | -0.006 | -1.3% | $0.437 | $0.469 | $0.437 | 86,300 | |
| $0.45 | -0.01 | -2.2% | $0.452 | $0.49 | $0.442 | 216,300 | |
| $0.46 | +0.013 | +2.9% | $0.445 | $0.479 | $0.445 | 125,700 | |
| $0.447 | -0.013 | -2.8% | $0.457 | $0.46 | $0.436 | 342,000 | |
| $0.46 | +0.016 | +3.6% | $0.45 | $0.467 | $0.427 | 252,600 | |
| $0.444 | -0.006 | -1.3% | $0.45 | $0.455 | $0.427 | 572,200 |
- Ticker
- NASDAQ:KTTA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 20 slides
Latest news
Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026
Oct 28, 2026
Closed $0.37 (-6.0%) on Oct 29, 2026
Pasithea Therapeutics Announces Positive PAS-004 Clinical Data from Phase 1 Advanced Cancer Study Presented at ESMO Congress 2026
Oct 23, 2026
Closed $0.405 (-9.0%) on Oct 23, 2026
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
Sep 14, 2026
Closed $0.51 (-3.8%) on Sep 14, 2026
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
Sep 3, 2026
Closed $0.58 (0.0%) on Sep 4, 2026
Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026
Jul 21, 2026
Closed $0.455 (-3.9%) on Jul 21, 2026
Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Jul 8, 2026
Closed $0.512 (-1.5%) on Jul 8, 2026
Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerability, and Durable Clinical Activity in MEK/BRAF-Pretreated Patients, plus Protocol Expansion
Jun 30, 2026
Closed $0.515 (-2.1%) on Jun 30, 2026
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Jun 16, 2026
Closed $0.51 (-8.9%) on Jun 16, 2026
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference
Jun 15, 2026
Closed $0.56 (-5.2%) on Jun 15, 2026
Pasithea Therapeutics Announces Orphan Drug Designation by FDA of PAS-004 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
Jun 2, 2026
Closed $0.645 (-9.8%) on Jun 2, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 20 slides · September 2026
IPO Roadshow (August 2021)
IPO roadshow · 17 slides · Aug 27, 2021
IPO Roadshow (August 2021)
IPO roadshow · 17 slides · Aug 6, 2021
IPO Roadshow (June 2021)
IPO roadshow · 15 slides · Jun 22, 2021
Pasithea Therapeutics Corp. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 108 in all · newest Oct 28, 2026 · oldest 2021
- Decks
- 4 decks · latest September 2026
Where Pasithea Therapeutics Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:KTTA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:KTTA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Pasithea Therapeutics Corp.